THE PLACE OF LYMPHOTROPIC ANTIBACTERIAL THERAPY IN THE TREATMENT OF TUBERCULOUS PLEURISY
DOI:
https://doi.org/10.34921/amj.2022.4.007Keywords:
tuberculous pleurisy, lymphotropic antibacterial therapy, tuberculosisAbstract
The article provides information about the research carried out to justify the lymphotropic method proposed by the authors for the antibacterial treatment of pleura. 67 patients with pleural tuberculosis were included in the main group. Patients of the comparison group (69 people) were treated according to the standard method. After two months of treatment in patients of the main group, tuberculosis bacteria were abacylated, and in patients of the comparison group – after four months. Residual changes in the pleural cavity (parietal stratification) were in 9 patients (13,4 %) of the studied main group. The intensity of antibiotic therapy, which was achieved by introducing drugs by the lymphotropic route, contributed to a decrease in the leading group of residual changes affecting the function of external respiration. In the comparison group, residual changes occurred in 6 – 77,6 %, and the process became chronic, which required surgical intervention in 14,4 % of patients. This indicates the advantage of the lymphotropic method of administering antibacterial drugs for tuberculous pleurisy.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Azerbaijan Medical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.